Wednesday 14 October 2026
Export UNH’s income statement to Excel — free account
UnitedHealth Group Incorporated
UNH Healthcare Healthcare Plans
UnitedHealth Group Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $447.6 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 61.5%, free cash flow grew 62.7% and total debt fell 5.43%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for ten.
377.76
0.76
−0.20%
Follow UNH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
26.75 | 20.44 | 25.03 | 18.02 |
+8 more quarters Free account |
P/S ratio |
0.83 | 0.55 | 0.67 | 0.72 | |
P/FCF ratio |
15.87 | 12.49 | 18.65 | 18.01 | |
P/Operating CF |
33.92 | 27.57 | 270.52 | 52.62 | |
P/B ratio |
3.59 | 2.36 | 2.99 | 3.08 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.92 | 0.64 | 0.77 | 0.81 | |
EV/EBITDA |
15.91 | 12.34 | 14.75 | 11.57 | |
EV/Operating CF |
15.28 | 12.35 | 17.46 | 16.92 | |
EV/FCF |
17.48 | 14.54 | 21.40 | 20.41 | |
Quick Ratio |
0.70 | 0.72 | 0.70 | 0.74 | |
Current Ratio |
0.78 | 0.80 | 0.79 | 0.82 | |
Net Debt/EBITDA |
4.21 | 4.01 | 29.53 | 7.72 | |
Debt/Assets |
22.44% | 22.85% | 23.36% | 22.96% | |
Debt/Equity |
0.67 | 0.69 | 0.72 | 0.71 | |
Asset Turnover |
1.46 | 1.45 | 1.47 | 1.42 | |
Operating CF/Net income |
2.02 | 1.42 | 110.80 | 2.53 | |
Capex/Depreciation |
(0.77) | (0.74) | (0.85) | (0.81) | |
Interest Coverage |
8.31 | 9.41 | 0.39 | 4.30 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.42 | 0.42 | 0.42 | 0.42 | |
Share Based Compensation of Revenue |
0.25% | 0.31% | 0.16% | 0.20% | |
Graham Net Nets |
(0.32) | (0.48) | (0.40) | (0.38) | |
Graham Number |
201.28 | 184.62 | 180.87 | 219.84 | |
Earnings Yield |
3.74% | 4.89% | 4.00% | 5.55% | |
Free Cash Flow Yield |
6.30% | 8.00% | 5.36% | 5.55% | |
Revenue per Share |
124.20 | 123.04 | 124.69 | 124.90 | |
Operating CF per Share |
12.25 | 9.82 | 1.22 | 6.56 | |
Capex per Share |
(0.89) | (0.84) | (1.04) | (0.98) | |
Free Cash Flow per Share |
11.37 | 8.97 | 0.18 | 5.58 | |
Cash per Share |
34.89 | 34.39 | 30.97 | 33.79 | |
Shareholders Equity per Share |
115.87 | 114.42 | 110.23 | 112.11 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
115.87 | 114.42 | 110.23 | 112.11 | |
Free Cash Flow |
10,253.00 | 8,149.00 | 160.00 | 5,055.00 | |
Working Capital |
(24,960.00) | (22,997.00) | (24,315.00) | (20,459.00) | |
Capital Expenditures |
(799.00) | (763.00) | (948.00) | (890.00) | |
Net Current Asset Value |
(118,354.00) | (117,622.00) | (118,909.00) | (118,633.00) | |
EV/EBIT |
19.05 | 15.18 | 18.14 | 13.45 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
17.30 | 13.04 | 15.81 | 11.87 | |
| Other line items | |||||
Average Receivables |
49,509.50 | 52,066.50 | 50,584.50 | 51,459.50 | |
Average Payables |
37,035.50 | 36,098.50 | 36,184.50 | 34,556.50 | |
Average Assets |
309,150.00 | 311,217.00 | 303,929.50 | 307,289.00 | |
Average Common Equity |
102,491.00 | 102,353.00 | 99,179.00 | 100,725.00 |
Columns are period end dates